IGC Pharma, Inc.
IGC· NYSE
IGCIGC Pharma, Inc.
Filed Aug 16, 2013 · 10-Q · 47 days after period end · 0001185185-13-001853
| Metric | Q1 2014 | Q1 2011 | Q1 2010 |
|---|---|---|---|
| Revenue | $1.12M | $1.06M | $1.13M |
| Net Income | -$633.49K | -$869.20K | -$591.17K |
| EPS Diluted | -$0.09 | -$0.04 | -$0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
IGC Pharma, Inc. · CIK 1326205 · Engraved from SEC EDGAR
ended Jun 30, 2013 · filed Aug 16, 2013 · 47 d after period end
